vs
Amarin Corp plc(AMRN)与MARINE PRODUCTS CORP(MPX)财务数据对比。点击上方公司名可切换其他公司
MARINE PRODUCTS CORP的季度营收约是Amarin Corp plc的1.4倍($64.6M vs $45.1M),MARINE PRODUCTS CORP净利率更高(3.7% vs -23.3%,领先26.9%),MARINE PRODUCTS CORP同比增速更快(35.0% vs 7.0%),过去两年MARINE PRODUCTS CORP的营收复合增速更高(-3.5% vs -18.3%)
Amarin是一家1993年成立的爱裔美籍生物制药企业,总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物,已推出处方级Omega-3脂肪酸药物Vascepa(AMR-101)。
Marine Products Corp旗下的West Marine是一家总部位于美国佛罗里达州劳德代尔堡的企业,在北美地区经营247家船艇用品及渔具零售连锁店,同时运营名为蓝色未来的非营利组织,品牌旗舰店面积超5万平方英尺,于2011年11月11日在劳德代尔堡正式开业。
AMRN vs MPX — 直观对比
营收规模更大
MPX
是对方的1.4倍
$45.1M
营收增速更快
MPX
高出28.0%
7.0%
净利率更高
MPX
高出26.9%
-23.3%
两年增速更快
MPX
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $45.1M | $64.6M |
| 净利润 | $-10.5M | $2.4M |
| 毛利率 | — | 19.6% |
| 营业利润率 | 35.5% | 5.8% |
| 净利率 | -23.3% | 3.7% |
| 营收同比 | 7.0% | 35.0% |
| 净利润同比 | 33.0% | -44.6% |
| 每股收益(稀释后) | — | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMRN
MPX
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $64.6M | ||
| Q3 25 | $49.7M | $53.1M | ||
| Q2 25 | $72.7M | $67.7M | ||
| Q1 25 | $42.0M | $59.0M | ||
| Q4 24 | $62.3M | $47.8M | ||
| Q3 24 | $42.3M | $49.9M | ||
| Q2 24 | $67.5M | $69.5M |
净利润
AMRN
MPX
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $2.4M | ||
| Q3 25 | $-7.7M | $2.6M | ||
| Q2 25 | $-14.1M | $4.2M | ||
| Q1 25 | $-15.7M | $2.2M | ||
| Q4 24 | $-48.6M | $4.3M | ||
| Q3 24 | $-25.1M | $3.4M | ||
| Q2 24 | $1.5M | $5.6M |
毛利率
AMRN
MPX
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 19.6% | ||
| Q3 25 | 44.7% | 19.2% | ||
| Q2 25 | 69.2% | 19.1% | ||
| Q1 25 | 59.8% | 18.6% | ||
| Q4 24 | -15.4% | 19.2% | ||
| Q3 24 | 38.5% | 18.4% | ||
| Q2 24 | 63.4% | 18.9% |
营业利润率
AMRN
MPX
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 5.8% | ||
| Q3 25 | -22.4% | 5.4% | ||
| Q2 25 | -22.0% | 7.1% | ||
| Q1 25 | -39.9% | 4.4% | ||
| Q4 24 | -84.3% | 7.7% | ||
| Q3 24 | -59.5% | 7.2% | ||
| Q2 24 | -0.8% | 8.3% |
净利率
AMRN
MPX
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 3.7% | ||
| Q3 25 | -15.6% | 5.0% | ||
| Q2 25 | -19.4% | 6.1% | ||
| Q1 25 | -37.4% | 3.7% | ||
| Q4 24 | -78.0% | 8.9% | ||
| Q3 24 | -59.4% | 6.8% | ||
| Q2 24 | 2.3% | 8.0% |
每股收益(稀释后)
AMRN
MPX
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.07 | ||
| Q3 25 | $-0.02 | $0.07 | ||
| Q2 25 | $-0.03 | $0.12 | ||
| Q1 25 | $-0.04 | $0.06 | ||
| Q4 24 | $-0.12 | $0.13 | ||
| Q3 24 | $-0.06 | $0.10 | ||
| Q2 24 | $0.00 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $125.0M |
| 总资产 | $645.8M | $147.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AMRN
MPX
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | — | ||
| Q2 24 | $306.7M | — |
股东权益
AMRN
MPX
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $125.0M | ||
| Q3 25 | $458.9M | $126.3M | ||
| Q2 25 | $464.9M | $127.2M | ||
| Q1 25 | $473.7M | $126.4M | ||
| Q4 24 | $486.2M | $129.0M | ||
| Q3 24 | $531.4M | $128.8M | ||
| Q2 24 | $551.9M | $129.3M |
总资产
AMRN
MPX
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $147.2M | ||
| Q3 25 | $659.8M | $179.5M | ||
| Q2 25 | $670.1M | $173.2M | ||
| Q1 25 | $655.7M | $182.9M | ||
| Q4 24 | $685.3M | $171.2M | ||
| Q3 24 | $750.6M | $176.3M | ||
| Q2 24 | $799.9M | $175.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $4.7M |
| 自由现金流经营现金流 - 资本支出 | — | $4.1M |
| 自由现金流率自由现金流/营收 | — | 6.4% |
| 资本支出强度资本支出/营收 | — | 0.9% |
| 现金转化率经营现金流/净利润 | — | 2.00× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势,按日历期对齐
经营现金流
AMRN
MPX
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $4.7M | ||
| Q3 25 | $-12.7M | $2.6M | ||
| Q2 25 | $16.6M | $-1.6M | ||
| Q1 25 | $-12.5M | $10.8M | ||
| Q4 24 | $-13.3M | $4.6M | ||
| Q3 24 | $-2.4M | $5.1M | ||
| Q2 24 | $-2.7M | $3.8M |
自由现金流
AMRN
MPX
| Q1 26 | — | — | ||
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $2.1M | ||
| Q2 25 | — | $-2.0M | ||
| Q1 25 | — | $10.7M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $3.0M |
自由现金流率
AMRN
MPX
| Q1 26 | — | — | ||
| Q4 25 | — | 6.4% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | — | 7.6% | ||
| Q3 24 | — | 6.5% | ||
| Q2 24 | — | 4.4% |
资本支出强度
AMRN
MPX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 1.1% |
现金转化率
AMRN
MPX
| Q1 26 | — | — | ||
| Q4 25 | — | 2.00× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | -0.39× | ||
| Q1 25 | — | 4.88× | ||
| Q4 24 | — | 1.09× | ||
| Q3 24 | — | 1.51× | ||
| Q2 24 | -1.81× | 0.68× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
MPX
| Boats And Accessories | $63.4M | 98% |
| Parts | $1.1M | 2% |